Newsbenzinga
Ionis To Present New Analyses From CORE And CORE2 Pivotal Studies Supporting Olezarsen For Severe Hypertriglyceridemia At Upcoming Congresses
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…